Stock Analysis

Insiders were the biggest winners as Themis Medicare Limited's (NSE:THEMISMED) market cap grew by ₹1.3b last week

NSEI:THEMISMED
Source: Shutterstock
Advertisement

Key Insights

  • Themis Medicare's significant insider ownership suggests inherent interests in company's expansion
  • A total of 5 investors have a majority stake in the company with 51% ownership
  • Using data from company's past performance alongside ownership research, one can better assess the future performance of a company
We've discovered 1 warning sign about Themis Medicare. View them for free.

To get a sense of who is truly in control of Themis Medicare Limited (NSE:THEMISMED), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 54% to be precise, is individual insiders. Put another way, the group faces the maximum upside potential (or downside risk).

As a result, insiders were the biggest beneficiaries of last week’s 11% gain.

Let's take a closer look to see what the different types of shareholders can tell us about Themis Medicare.

Check out our latest analysis for Themis Medicare

ownership-breakdown
NSEI:THEMISMED Ownership Breakdown May 16th 2025

What Does The Institutional Ownership Tell Us About Themis Medicare?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Institutions have a very small stake in Themis Medicare. That indicates that the company is on the radar of some funds, but it isn't particularly popular with professional investors at the moment. So if the company itself can improve over time, we may well see more institutional buyers in the future. It is not uncommon to see a big share price rise if multiple institutional investors are trying to buy into a stock at the same time. So check out the historic earnings trajectory, below, but keep in mind it's the future that counts most.

earnings-and-revenue-growth
NSEI:THEMISMED Earnings and Revenue Growth May 16th 2025

We note that hedge funds don't have a meaningful investment in Themis Medicare. Rajneesh Anand is currently the company's largest shareholder with 16% of shares outstanding. With 11% and 9.6% of the shares outstanding respectively, Dinesh Patel and Gedeon Richter Investments Management Ltd are the second and third largest shareholders. Dinesh Patel, who is the second-largest shareholder, also happens to hold the title of Top Key Executive. Furthermore, CEO Sachin Patel is the owner of 6.0% of the company's shares.

Our research also brought to light the fact that roughly 51% of the company is controlled by the top 5 shareholders suggesting that these owners wield significant influence on the business.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

Insider Ownership Of Themis Medicare

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

It seems that insiders own more than half the Themis Medicare Limited stock. This gives them a lot of power. Given it has a market cap of ₹13b, that means they have ₹6.8b worth of shares. Most would be pleased to see the board is investing alongside them. You may wish todiscover (for free) if they have been buying or selling.

General Public Ownership

The general public, who are usually individual investors, hold a 22% stake in Themis Medicare. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Private Company Ownership

It seems that Private Companies own 22%, of the Themis Medicare stock. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 1 warning sign for Themis Medicare you should know about.

If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Valuation is complex, but we're here to simplify it.

Discover if Themis Medicare might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.